Harvard Endowment Leader Stephen Blyth On Medical Leave

Stephen Blyth on temporary leave of absence 

Stephen Blyth
Photograph by Stephanie Mitchell/Harvard Public Affairs and Communications

The University announced this morning that Stephen Blyth, president and chief executive officer of Harvard Management Company—which invests the endowment assets—is taking a temporary medical leave of absence, effective immediately. Blyth assumed his current responsibilities just 17 months ago, effective January 1, 2015, and was engaged in a thorough review and redirection of the management company and its investment processes, as described here, after a period of disappointing investment returns. Apart from the obvious personal concerns for Blyth’s health, his absence comes at a challenging time for the organization. The University statement follows; given the personal nature of the announcement, no further details are being released at this time.

Harvard Management Company, Inc. (HMC) today announced that Stephen Blyth, HMC’s President and Chief Executive Officer, will take a temporary medical leave of absence. The temporary leave takes effect today, Monday, May 23.

HMC’s Board of Directors have appointed Robert Ettl, HMC’s Chief Operating Officer, as interim CEO until Mr. Blyth’s return. Mr. Ettl joined HMC in 2008.

In the interim period, Rene Canezin, Head of Fixed Income, Credit, and Commodities, and Rich Hall, Head of Private Equity, will serve as co-chairs of HMC's Investment Committee.

“We have a highly-experienced executive team at HMC and, together with Bob, they will provide strong leadership in Stephen's absence,” said Paul J. Finnegan, Chair of HMC’s Board of Directors. “We look forward to Stephen's return to the company, and wish him well as he returns to full health."

 

 

You might also like

The Faculty of Arts and Sciences Zeroes In on the Classroom Experience

Class schedules and academics are at the top of the agenda for Harvard faculty.

Harvard Football: Harvard 59, Holy Cross 24

Another week, another blowout, this one against an in-state rival

Trump Says a Deal with Harvard Is Close

Administration squeezes Harvard finances, and a federal judge blasts deportation efforts as unconstitutional.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Three Harvardians Win Macarthur Fellowships

A mathematician, a political scientist, and an astrophysicist are honored with “genius” grants for their work.

Explore More From Current Issue

Two people moving large abstract painting with blue V-shaped design in museum courtyard.

A Harvard Art Museums Painting Gets a Bath

Water and sunlight help restore a modern American classic.

Public health dean Andrea Baccarelli wearing a white collared shirt and glasses.

The School of Public Health, Facing a Financial Reckoning, Seizes the Chance to Reinvent Itself

Dean Andrea Baccarelli plans for a smaller, more impactful Chan School of 2030.

Man in gray sweater standing in hallway with colorful abstract art on wall.

How Do Single-Celled Organisms Learn and Remember

A Harvard neuroscientist’s quest to model memory in single-celled organisms